These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 8076927)

  • 1. Alterations in hypothalamic mu-opiate receptor-mediated responses but not methionine enkephalin or proenkephalin messenger RNA levels in rats with acute cholestasis.
    Swain MG
    Hepatology; 1994 Sep; 20(3):700-5. PubMed ID: 8076927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis.
    Swain MG; Patchev V; Vergalla J; Chrousos G; Jones EA
    J Clin Invest; 1993 May; 91(5):1903-8. PubMed ID: 8387536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective corticotropin-releasing hormone mediated neuroendocrine and behavioral responses in cholestatic rats: implications for cholestatic liver disease-related sickness behaviors.
    Swain MG; Maric M
    Hepatology; 1995 Nov; 22(5):1560-4. PubMed ID: 7590676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of acute "binge" cocaine on preprodynorphin, preproenkephalin, proopiomelanocortin, and corticotropin-releasing hormone receptor mRNA levels in the striatum and hypothalamic-pituitary-adrenal axis of mu-opioid receptor knockout mice.
    Zhou Y; Spangler R; Schlussman SD; Yuferov VP; Sora I; Ho A; Uhl GR; Kreek MJ
    Synapse; 2002 Sep; 45(4):220-9. PubMed ID: 12125043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in hypothalamic preproenkephalin A mRNA following stress and opiate withdrawal.
    Lightman SL; Young WS
    Nature; 1987 Aug 13-19; 328(6131):643-5. PubMed ID: 3614366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
    Calogero AE; Scaccianoce S; Burrello N; Nicolai R; Muscolo LA; Kling MA; Angelucci L; D'Agata R
    J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein kinase A maintains cellular tolerance to mu opioid receptor agonists in hypothalamic neurosecretory cells with chronic morphine treatment: convergence on a common pathway with estrogen in modulating mu opioid receptor/effector coupling.
    Wagner EJ; Rønnekleiv OK; Kelly MJ
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1266-73. PubMed ID: 9618432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid modulation of the fetal hypothalamic-pituitary-adrenal axis: the role of receptor subtypes and route of administration.
    Taylor CC; Wu D; Soong Y; Yee JS; Szeto HH
    J Pharmacol Exp Ther; 1997 Apr; 281(1):129-35. PubMed ID: 9103489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
    Capasso A; Sorrentino L
    Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenal secretion of BAM-22P, a potent opioid peptide, is enhanced in rats with acute cholestasis.
    Swain MG; MacArthur L; Vergalla J; Jones EA
    Am J Physiol; 1994 Feb; 266(2 Pt 1):G201-5. PubMed ID: 8141292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous opioids accumulate in plasma in a rat model of acute cholestasis.
    Swain MG; Rothman RB; Xu H; Vergalla J; Bergasa NV; Jones EA
    Gastroenterology; 1992 Aug; 103(2):630-5. PubMed ID: 1634078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by three selective type-4 phosphodiesterase inhibitors: in vitro and in vivo studies.
    Kumari M; Cover PO; Poyser RH; Buckingham JC
    Br J Pharmacol; 1997 Jun; 121(3):459-68. PubMed ID: 9179387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-related decrease in hypothalamic gonadotropin-releasing hormone (GnRH) gene expression, but not pituitary responsiveness to GnRH, in the male Brown Norway rat.
    Gruenewald DA; Naai MA; Marck BT; Matsumoto AM
    J Androl; 2000; 21(1):72-84. PubMed ID: 10670522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Portacaval anastomosis induces region-selective alterations of the endogenous opioid system in the rat brain.
    de Waele JP; Audet RM; Leong DK; Butterworth RF
    Hepatology; 1996 Oct; 24(4):895-901. PubMed ID: 8855194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipopolysaccharide induces preproenkephalin transcription in hypophysiotropic neurons of the rat paraventricular hypothalamic nucleus suggesting a neuroendocrine role for enkephalins during immune stress.
    Engström L; Mackerlova L; Blomqvist A
    Neuroscience; 2006 Oct; 142(3):781-8. PubMed ID: 16949213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amygdalar vasopressin mRNA increases in acute cocaine withdrawal: evidence for opioid receptor modulation.
    Zhou Y; Bendor JT; Yuferov V; Schlussman SD; Ho A; Kreek MJ
    Neuroscience; 2005; 134(4):1391-7. PubMed ID: 16039786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous i.c.v. infusion of brain-derived neurotrophic factor modifies hypothalamic-pituitary-adrenal axis activity, locomotor activity and body temperature rhythms in adult male rats.
    Naert G; Ixart G; Tapia-Arancibia L; Givalois L
    Neuroscience; 2006 May; 139(2):779-89. PubMed ID: 16457953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of selective D1- or D2-like dopamine receptor antagonists with acute "binge" pattern cocaine on corticotropin-releasing hormone and proopiomelanocortin mRNA levels in the hypothalamus.
    Zhou Y; Spangler R; Yuferov VP; Schlussmann SD; Ho A; Kreek MJ
    Brain Res Mol Brain Res; 2004 Nov; 130(1-2):61-7. PubMed ID: 15519677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional mu opioid receptors are expressed in cholinergic interneurons of the rat dorsal striatum: territorial specificity and diurnal variation.
    Jabourian M; Venance L; Bourgoin S; Ozon S; Pérez S; Godeheu G; Glowinski J; Kemel ML
    Eur J Neurosci; 2005 Jun; 21(12):3301-9. PubMed ID: 16026468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corticotropin-releasing factor and type 1 corticotropin-releasing factor receptor messenger RNAs in rat brain and pituitary during "binge"-pattern cocaine administration and chronic withdrawal.
    Zhou Y; Spangler R; LaForge KS; Maggos CE; Ho A; Kreek MJ
    J Pharmacol Exp Ther; 1996 Oct; 279(1):351-8. PubMed ID: 8859013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.